title: [Kidney cancer management in 2007: news and recommendations].
abstract: In case of a single renal cell carcinoma strictly located in the kidney, the radical nephrectomy remains the treatment of choice. However, it has been estimated that nearly 30 to 40 % of renal cell carcinoma are about to recur after primitive surgery. In certain cases, conservative surgery can be discussed as an alternative to radical treatment, especially in case of exophytic renal tumour or less than 4 cm in diameter. New ablative techniques (radiofrequency and cryoablation) have shown promising results but the follow-up is still very limited. French national recommendation regarding kidney cancer have been updated in 2007 and following the development of clinical trials using antiangiogenic agents. Regarding the use of antiangiogenic agents, several points have to be taken into account: existence of renal cell carcinoma, presence of metastasis, number of metastasis, location and risk factor prognosis determination.
authors.affiliation: Service d'Urologie, Hôpital Pitié-Salpétrière, AP-HP, Groupe Hospitalo-universitaire Est, Faculté de médecine Pierre et Marie Curie, Université Paris VI, Paris, France.
authors.forename: J-N
authors.initials: JN
authors.lastname: Cornu
authors.forename: M
authors.initials: M
authors.lastname: Rouprêt
authors.forename: H
authors.initials: H
authors.lastname: Lang
authors.forename: J-A
authors.initials: JA
authors.lastname: Long
authors.forename: Y
authors.initials: Y
authors.lastname: Neuzillet
authors.forename: J-J
authors.initials: JJ
authors.lastname: Patard
authors.forename: T
authors.initials: T
authors.lastname: Piéchaud
authors.forename: J-M
authors.initials: JM
authors.lastname: Corréas
authors.forename: M
authors.initials: M
authors.lastname: de Fromont
authors.forename: B
authors.initials: B
authors.lastname: Escudier
authors.forename: A
authors.initials: A
authors.lastname: Méjean
mesh_terms: D000465:Algorithms; D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*; D017410:Practice Guidelines as Topic